New data show Ferriprox is more efficacious than deferoxamine
Results from two new studies demonstrate that treatment with the oral iron chelator Ferriprox(deferiprone) prevents iron-induced heart disease and significantly reduces the risk of early cardiac death in patients who undergo regular blood transfusions to treat thalassemia, a genetic disease that affects the body's ability to make red blood cells. ...... Thalassemia is a life-long condition requir...